Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $7.64 USD
Change Today +0.16 / 2.14%
Volume 812.2K
TXMD On Other Exchanges
As of 8:04 PM 11/25/15 All times are local (Market data is delayed by at least 15 minutes).

therapeuticsmd inc (TXMD) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/23/15 - $8.83
52 Week Low
12/15/14 - $3.44
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for THERAPEUTICSMD INC (TXMD)

Related News

No related news articles were found.

therapeuticsmd inc (TXMD) Related Businessweek News

No Related Businessweek News Found

therapeuticsmd inc (TXMD) Details

TherapeuticsMD, Inc. operates as a women’s health care product company. The company manufactures and distributes prescription and over-the-counter product lines, including prenatal vitamins, iron supplements, vitamin D supplements, and natural menopause relief products under the vitaMedMD brand, as well as duplicate formulations of its prescription prenatal vitamins products under the BocaGreenMD Prena1 name. The company also focuses on conducting the clinical trials for hormone therapy pharmaceutical products that are designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis, and vaginal discomfort. In addition, it manufactures and distributes branded and generic prescription prenatal, as well as OTC vitamins. TherapeuticsMD markets its products primarily through a direct national sales force to health care providers, as well as directly through its Website. The company was founded in 2008 and is headquartered in Boca Raton, Florida.

100 Employees
Last Reported Date: 03/12/15
Founded in 2008

therapeuticsmd inc (TXMD) Top Compensated Officers

Co-Founder, Chief Executive Officer and Direc...
Total Annual Compensation: $550.0K
President, Secretary and Director
Total Annual Compensation: $350.0K
Chief Financial Officer, Vice President of Fi...
Total Annual Compensation: $345.0K
Executive Vice President and Chief Strategy P...
Total Annual Compensation: $213.2K
Vice President of Finance
Total Annual Compensation: $150.0K
Compensation as of Fiscal Year 2014.

therapeuticsmd inc (TXMD) Key Developments

TherapeuticsMD, Inc. Presents at Stifel Healthcare Conference 2015, Nov-17-2015 10:15 AM

TherapeuticsMD, Inc. Presents at Stifel Healthcare Conference 2015, Nov-17-2015 10:15 AM. Venue: The New York Palace Hotel, Hubbard Room, New York, New York, United States. Speakers: Robert G. Finizio, Co-Founder, Chief Executive Officer and Director.

TherapeuticsMD Seek Acquisitions

TherapeuticsMD, Inc. (AMEX:TXMD) has made an offering of $250.00 million. The proceeds will be used for general corporate purposes, which may include the repayment of indebtedness outstanding from time to time and for working capital, capital expenditures, acquisitions and repurchases of our common stock or other securities.

TherapeuticsMD, Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2015

TherapeuticsMD, Inc. reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2015. For the quarter, the company reported revenues, net for the company’s prescription prenatal vitamin business increased to $5,190,175 compared with $4,186,261 for the third quarter of 2014. Revenue growth during the third quarter was primarily driven by increased number of units sold, product mix, and average net sales price of the company’s prenatal vitamin products. Operating loss was $19,503,035 against $17,847,875 a year ago. Loss before income taxes was $19,472,645 against $17,832,251 a year ago. Net loss was $19,472,645 against $17,832,251 a year ago. Net loss per basic and diluted share was $0.11 against $0.12 a year ago. For the nine months, the company reported revenues, net of $14,513,158 against $10,768,572 a year ago. Operating loss was $67,681,237 against $37,725,769 a year ago. Loss before income taxes was $67,594,347 against $37,914,629 a year ago. Net loss was $67,594,347 against $37,914,629 a year ago. Net loss per basic and diluted share was $0.39 against $0.26 a year ago. Net cash used in operating activities was $62,434,546 against $30,235,734 a year ago. Purchase of property and equipment was $15,559 against $30,962 a year ago.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TXMD:US $7.64 USD +0.16

TXMD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for TXMD.
View Industry Companies

Industry Analysis


Industry Average

Valuation TXMD Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 70.6x
Price/Book 17.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 66.5x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact THERAPEUTICSMD INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at